Roche Diagnostics and BIOTECON Diagnostics have entered into a licensing agreement concerning Roche’s LightCycler system technology. Under the terms of the agreement, Roche grants a non-exclusive ...
The new LightCycler Nano instrument shares the state-of-the-art technology of the LightCycler portfolio, producing high quality data in qPCR, genotyping, and high resolution melting on a small ...
The LightCycler PRO System is designed to be the most advanced qPCR technology for both clinical diagnostics and research. The new system will advance personalised healthcare and support outbreak ...
PENZBERG, Germany--(BUSINESS WIRE)-- Roche (SIX:RO)(SIX:ROG)(OTCQX:RHHBY) and Ghent University (Belgium) have signed an agreement for the use of Roche's LightCycler® 1536 Instrument in various cancer ...
We will discuss the Digital LightCycler System, a digital PCR (dPCR) system for DNA and RNA with 6-color capability for flexible, multiplexed biomarker detection. With advances in sensitivity, ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. launch of the latest addition to the company's real-time PCR portfolio of LightCycler® instruments for use in research, the LightCycler Nano ...
Quantification of residual leukemic cells at early time points during therapy can reliably predict the outcome in children with acute lymphoblastic leukemia (ALL). Recently, semiquantitative minimal ...
PENZBERG, Germany--(BUSINESS WIRE)-- With “Size: Reduced. Fun: Amplified.”, Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) launched its new real-time PCR system on June 27th, 2011. The small, ...
Small platform supporting state-of-the-art technology for fast PCR protocols introduced at American Society of Human Genetics meeting in Montreal The new LightCycler Nano instrument shares the ...
Small platform supporting state-of-the-art technology for fast PCR protocols introduced at American Society of Human Genetics meeting in Montreal The new LightCycler Nano instrument shares the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results